Ebola vaccine being used in Congo produces lasting antibody response, study finds
A new study by UCLA researchers and colleagues demonstrates that the Ebola vaccine known as rVSVĪG-ZEBOV-GP results in a robust and enduring antibody response among vaccinated individuals in areas of the Democratic Republic ...
Feb 8, 2022
1
407